Danaher | DHR - Capital Ordinário

Preço das Ações
177.25
Mudança Diária
-1.32 -0.74%
Mensal
-5.29%
Anual
-10.09%
Q2 Previsão
173.46




Capital Ordinário Alterar Data
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.7M 358K 2025-12
Align Technology USD 71.75M 736K 2025-12
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Boston Scientific USD 1.48B 2.66M 2025-12
Bruker USD 151.94M 225K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 199.5M 196.5M 2025-09
Edwards Lifesciences USD 580.7M 0 2025-12
ESCO Technologies USD 25.83M 4K 2025-09
Fortive USD 313.4M 4.2M 2025-12
Henry Schein USD 115.77M 2.8M 2025-12
Illumina USD 152.8M 900K 2025-12
Intuitive Surgical USD 355.17M 674K 2026-03
IQVIA Holdings USD 169.6M 700K 2025-12
Keysight Technologies USD 171.8M 600K 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
OraSure Technologies USD 70.39M 1.87M 2025-12
Quest Diagnostics USD 111M 1000K 2026-03
Quidel USD 67.9M 200K 2025-09
Repligen USD 56.32M 42K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Roper Industries USD 102.4M 4.2M 2026-03
Stryker USD 382.4M 93K 2025-12
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Waters USD 98.08M 38.55M 2025-12
Zimmer Biomet Holdings USD 198.18M 18.44K 2025-12